Back
AmeraMex International 10K Form
Sell
34
AMMX
AmeraMex International
Last Price:
0.35
Seasonality Move:
6.08%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2021-05-17 | 10Q | AMMX/AmeraMex International Quarterly |
2020-11-13 | 10Q | AMMX/AmeraMex International Quarterly |
2020-08-14 | 10Q | AMMX/AmeraMex International Quarterly |
2020-07-14 | 10Q | AMMX/AmeraMex International Quarterly |
2020-06-24 | 10Q | AMMX/AmeraMex International Quarterly |
2020-06-05 | 10K | AMMX/AmeraMex International Annual |
Receive AMMX News And Ratings
See the #1 stock for the next 7 days that we like better than AMMX
AMMX Financial Statistics
Sales & Book Value
Annual Sales: | $19.22M |
---|---|
Cash Flow: | $121.8K |
Price / Cash Flow: | 0 |
Annual Sales: | $0.27 |
Price / Book: | 0 |
Profitability
EPS (TTM): | 0.04000 |
---|---|
Net Income (TTM): | $619.7K |
Gross Margin: | $4.49M |
Return on Equity: | 15.28% |
Return on Assets: | 4.55% |
AmeraMex International Earnings Forecast
Key AmeraMex International Financial Ratios
- The Gross Profit Margin over the past 7 years for AMMX is 23.34%.
- The Selling, General & Administrative Expenses for AMMX have been equal to 14.18% of Gross Profit Margin.
- The Interest Expense is 78.13% of Operating Income.
- The Net Earning history of AMMX is 4.53% of Total Revenues.
- Per Share Earnings over the last 7 years have been positive in 2 years.
AmeraMex International Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | OTCM |
---|---|
Industry: | Trading Companies & Distributors |
Sector: | Industrials |
Current Symbol: | AMMX |
Website: | ammx.net |
Debt
Debt-to-Equity Ratio: | 1.49 |
---|---|
Current Ratio: | 1.92 |
Quick Ratio: | 0.38 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
AMMX Technical Analysis vs Fundamental Analysis
Sell
34
AmeraMex International (AMMX)
is a Sell
Is AmeraMex International a Buy or a Sell?
-
AmeraMex International stock is rated a Sell
The current AmeraMex International [AMMX] share price is $0.35. The Score for AMMX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.